Pharma's cold need is opportunity in all parts of supply chain

The cold chain is hot again. AMR's ($AMR) American Airlines Cargo division is expanding its cold-chain service, ExpediteTC. The expansion is called ExpediteTC Passive, and it provides expedited handling and monitoring to support ambient temperature control.

The Passive offering augments the company's existing Active service, based on dry ice and battery-powered containers to regulate temperature levels, reports Healthcare Packaging.

The announcement is one of many recent offerings by virtually all logistics links in the supply chain.

For example, Indianapolis International Airport announced in July the strengthening of its cold-chain capabilities and enhancements to its biopharma delivery services.

Earlier this month, manufacturing service provider Catalent announced facility expansions to keep pace with increasing customer demand in the U.S., U.K. and Germany. Logistics service providers DB Schenker, DHL, UPS ($UPS), and Fed Ex ($FDX) have all struck big pharma deals or announced significant cold chain services in the past year.

Cold chain product makers see the pharma fruit, too. CryoPort ($CYRX) is targeting the frozen shipping market with products that both benefit life sciences companies and represent green technology solutions.

- see the story

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.